Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Notalgia Paresthetica (KOMFORT)
Completed · Phase 2 · Has a placebo group
Conditions studied: Pruritus, Notalgia Paresthetica
In brief
This is a multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of twice-daily (BID) oral difelikefalin (CR845) in adult subjects with notalgia paresthetica and moderate to severe pruritus.
Key facts
- Study ID
- NCT04706975
- Run by
- Cara Therapeutics, Inc.
- People needed
- 126
- Starts
- 2021-01-11
- Expected to finish
- 2022-06-30
- Last updated by the study team
- 2023-05-22
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Cara Therapeutics Study Site — Fort Smith, Arkansas, United States
- Cara Therapeutics Study Site — Hot Springs, Arkansas, United States
- Cara Therapeutics Study Site — Rogers, Arkansas, United States
- Cara Therapeutics Study Site — Fountain Valley, California, United States
- Cara Therapeutics Study Site — Los Angeles, California, United States
- Cara Therapeutics Study Site — San Diego, California, United States
- Cara Therapeutics Study Site — Santa Monica, California, United States
- Cara Therapeutics Study Site — Cromwell, Connecticut, United States
- Cara Therapeutics Study Site — Coral Gables, Florida, United States
- Cara Therapeutics Study Site — Margate, Florida, United States
- Cara Therapeutics Study Site — Miami, Florida, United States
- Cara Therapeutics Study Site — North Miami Beach, Florida, United States
- Cara Therapeutics Study Site — Sandy Springs, Georgia, United States
- Cara Therapeutics Study Site — Indianapolis, Indiana, United States
- Cara Therapeutics Study Site — Plainfield, Indiana, United States
- Cara Therapeutics Study Site — Metairie, Louisiana, United States
- Cara Therapeutics Study Site — New York, New York, United States
- Cara Therapeutics Study Site — High Point, North Carolina, United States
- Cara Therapeutics Study Site — Columbus, Ohio, United States
- Cara Therapeutics Study Site — Charleston, South Carolina, United States
- Cara Therapeutics Study Site — Bellaire, Texas, United States
- Cara Therapeutics Study Site — Pflugerville, Texas, United States
- Cara Therapeutics Study Site — San Antonio, Texas, United States
- Cara Therapeutics Study Site — Salt Lake City, Utah, United States
- Cara Therapeutics Study Site — Norfolk, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.